Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Oleksandr Telnov"'
Autor:
Oleksandr Telnov, Veronica Alvarez, Elena Graglia, Lucas Molfino, Philipp du Cros, Michael Rich
Publikováno v:
International Journal of Infectious Diseases, Vol 84, Iss , Pp 138-140 (2019)
We present a case report describing outcomes in a 21 year old HIV-negative man who received treatment with bedaquiline. Due to error, dosage received comprised 4 pills of 100 mg every second day in the 60 days following the first two weeks of 4 pills
Externí odkaz:
https://doaj.org/article/89408cf6b9ea49c09e4c4005857a22c9
Autor:
Sekai Chenai Mathabire Rucker, Loide Cossa, Rebecca E. Harrison, James Mpunga, Sheila Lobo, Patrick Kisaka Kimupelenge, Felix Mandar Kol’Ampwe, Isabel Amoros Quiles, Lucas Molfino, Elisabeth Szumilin, Oleksandr Telnov, Zibusiso Ndlovu, Helena Huerga
Publikováno v:
Global Health Action, Vol 12, Iss 1 (2019)
Background: Determine TB-LAM is a urine-based point-of-care assay for diagnosis of tuberculosis (TB). Objective: To assess the feasibility of using LAM to diagnose TB in adult HIV-positive patients in resource-limited settings. Methods: We performed
Externí odkaz:
https://doaj.org/article/61606dae197d4ec3a560c74190955cbc
Autor:
Michael Rich, Philipp du Cros, Lucas Molfino, Veronica Alvarez, Oleksandr Telnov, Elena Graglia
Publikováno v:
International Journal of Infectious Diseases, Vol 84, Iss, Pp 138-140 (2019)
We present a case report describing outcomes in a 21 year old HIV-negative man who received treatment with bedaquiline. Due to error, dosage received comprised 4 pills of 100 mg every second day in the 60 days following the first two weeks of 4 pills
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::26aabaec14a24f40eb837ec857d94dea
https://doi.org/10.1016/j.ijid.2019.03.035
https://doi.org/10.1016/j.ijid.2019.03.035
Autor:
Masoud Dara, Matteo Zignol, Kristin Kremer, L Turaev, P. du Cros, B Kholikulov, W van Gemert, Andrei Dadu, Dennis Falzon, Dilrabo Ulmasova, P. de Colombani, Harald Hoffmann, Oleksandr Telnov, G Uzakova, M N Tillyashayhov, N Muslimova, T Gombogaram, Jamshid Gadoev, Avazbek Jalolov, A Slizkiy
Publikováno v:
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin. 18(42)
Multidrug-resistant tuberculosis (MDR-TB; resistance to at least rifampicin and isoniazid) is a global public health concern. In 2010–2011, Uzbekistan, in central Asia, conducted its first countrywide survey to determine the prevalence of MDR-TB am
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::65c1cb7ebd9d8dab54474b02a99c74a5
https://pubmed.ncbi.nlm.nih.gov/24176581
https://pubmed.ncbi.nlm.nih.gov/24176581